Paeoniae Radix Extract for Cachexia Muscle Loss

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for cachexia, particularly in cancer patients, are either ineffective in the long term or come with significant side effects, and there is a need for a safer and more effective therapy that can address muscle loss and appetite reduction associated with cachexia and anticancer therapies.

Innovation Solution

A pharmaceutical composition containing Paeoniae radix extract as an active ingredient, obtained through solvent extraction and potentially combined with pharmaceutically acceptable carriers, is developed to alleviate symptoms of cachexia, muscle loss, and hematopoietic toxicity, and can be administered orally or parenterally.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Duration of action of moving object

If steroids are used for long-term treatment of cachexia, then therapeutic effect is maintained, but side effects such as water retention, insulin resistance, and adrenal gland hypofunction occur

Engineering Contradiction:
Improveduration of therapeutic effectVSAvoidside effects
Core Design Contradiction:
Duration of action of moving objectVSObject-affected harmful factors

Solution Approach 1:

The patent replaces long-term steroid therapy with a herbal composition based on Paeoniae radix that can be used continuously without accumulating harmful side effects. The herbal composition acts as a safe alternative that maintains therapeutic effects without the progressive damage caused by steroids, effectively substituting a harmful long-term treatment with a benign one.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The patent introduces Paeoniae radix extract as an intermediary substance that mediates between the need for long-term cachexia treatment and the avoidance of steroid side effects. This herbal composition serves as a bridge therapy that provides sustained therapeutic benefits while eliminating the harmful effects associated with conventional steroid therapy.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Quantity of substance

If progesterone formulation is used for treatment of cachexia, then weight loss is addressed, but adipose tissue increases rather than muscle, and side effects occur

Engineering Contradiction:
ImproveweightVSAvoidside effects and tissue composition
Core Design Contradiction:
Quantity of substanceVSObject-affected harmful factors

Solution Approach 1:

The patent applies local quality by specifying that the Paeoniae radix extract should be processed to contain particular active components (such as paeoniflorin and other phenolic compounds) that selectively promote muscle preservation rather than general weight gain. This targeted approach ensures that the weight effect is localized to muscle tissue rather than adipose tissue.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent changes the parameter of tissue composition by using Paeoniae radix extract that has been processed to specific active ingredient profiles. This parameter change in the composition's chemical makeup enables it to produce muscle-preserving effects rather than adipose accumulation, distinguishing it from conventional progesterone therapy.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If anticancer therapy is administered, then cancer is treated, but cachexia and muscle loss occur as side effects

Engineering Contradiction:
Improvecancer treatment effectivenessVSAvoidcachexia and muscle loss
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent converts the harmful effect of anticancer therapy-induced cachexia into a beneficial outcome by using Paeoniae radix extract to counteract the catabolic state. The herbal composition transforms the harmful muscle loss and weight loss caused by chemotherapy into a protective effect, preserving muscle mass and improving nutritional status during cancer treatment.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Solution Approach 2:

The patent introduces Paeoniae radix extract as an intermediary that mediates between anticancer therapy and the patient's nutritional status. This herbal composition acts as a protective agent that reduces the harmful effects of chemotherapy on muscle and fat metabolism, allowing cancer treatment to proceed while preventing cachexia.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The Paeoniae radix extract composition effectively increases food intake, muscle weight, and muscle strength, while reducing inflammatory cytokines and hematopoietic toxicity, thereby improving the quality of life for patients with cachexia and muscle loss.

Implementation Method 1

The Paeoniae radix extract composition effectively increases food intake, muscle weight, and muscle strength, while reducing inflammatory cytokines and hematopoietic toxicity

Methodology Applied
Scientific EffectPharmacological activity:

Data Source

PatentUS11684650B2Composition for preventing, alleviating, or treating cachexia and muscle loss
Publication Date: 2023.06.27 UMT CO LTD
  • US11684650B2 patent drawing
  • US11684650B2 patent drawing
  • US11684650B2 patent drawing

AI summary

The present disclosure relates to a composition containing a Paeoniae radix extract as an active ingredient. The composition may alleviate inappetence, weight loss, muscle loss and fatigue and inhibit hematopoietic toxicity. Thus, the composition may be effectively used for the prevention, alleviation or treatment of cachexia and muscle loss.